Cost-effectiveness of upstream versus selective glycoprotein Ilb/IIIa inhibitors for acute coronary syndromes

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)276-276
Number of pages1
JournalJournal of the American College of Cardiology
Volume49
Issue number2
Publication statusPublished - 2007

Cite this